A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Childrens Hospital Colorado
Study ID
Protocol Number: 20-2113
More information available at ClinicalTrials.gov: NCT04490915
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers